Refine Results
- Products
- Content Type
- Analysis Platform
- Language
1 - 10 of 10 results
A protocol for mitocondrial isolation and oxygen consumption analysis using the Agilent MitoXpress Xtra oxygen consumption assay.
Learn about a customized workflow to standardize the identification/investigation of mitochondrial toxicity using Agilent Seahorse XF technology.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
A demonstration of combining microelectrode-based iPS cardiomyocyte contractility measurements with microplate-based bioenergetics assessment to characterize cellular responses to drug treatment.
A demonstration of the performance of the Agilent MitoXpress Xtra oxygen consumption assay for identifying drug induced mitocondrial toxicity.
Screening for Drug-Induced Mitochondrial Dysfunction Using MitoXpress Xtra on Isolated Mitochondria
| French (France) | Complete (PDF) |
|---|---|
| German (Germany) | Complete (PDF) |
| Italian (Italy) | Complete (PDF) |
| Spanish (Spain) | Complete (PDF) |
Learn about the principle and parameter calculations in the Agilent Seahorse XF Mito Tox assay solution used to assess mitochondrial toxicity
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
Two Workflows: A Streamlined 384-well workflow to detect direct drug-induced mitochondrial dysfunction and Multiplexed workflow to detect mitochondrial toxicity after longer treatments
Multiplexed Screening of Drug-Induced Mitochondrial Dysfunction and Cytotoxicity
Poster - Cell-based Screening of Drug-Induced Metabolic Dysfunction
This poster Demonstrates the utility of Agilent Seahorse XF Real-Time ATP Rate Assay Kit and PMP in testing compound tox and understanding mechanism.